1-3 of 3
Guilan Li, M.S
Close
Sort by
Journal Articles

A Novel Orally Available Proteasome Inhibitor NPI-0052 Induces Killing in Multiple Myeloma (MM) Cells Resistant to Conventional and Bortezomib Therapies.

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Klaus Podar, Ph.D, Teru Hideshima, Ph.D, Reshma Shrigarpure, Ph.D, Laurence Catley, M.D, Constantine Mitsiades, Ph.D, Nikhil Munshi, M.D, Robert Sclossman, M.D, Rena Bahjat, Ph.D, Saskia Neuteboom, M.D., Paul Richardson, M.D, Michael Palladino, Ph.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2004) 104 (11): 2405.
https://doi.org/10.1182/blood.V104.11.2405.2405
Published: 2004
Journal Articles

Mitochondria and Caspase-Independent Cell-Death Triggered by GCS-100, a Novel Carbohydrate-Based Therapeutic in Multiple Myeloma (MM) Cells.

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Klaus Podar, Ph.D, Teru Hideshima, Ph.D, Kenji Ishitsuka, M.D, Laurence Catley, M.D, Martin Sattler, Ph.D, Yu-Tzu Tai, Ph.D, Renate Burger, Ph.D, Paul Richardson, M.D, Yan Chang, Ph.D, Joanne Schindler, M.D, Bradley Carver, M.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2004) 104 (11): 2456.
https://doi.org/10.1182/blood.V104.11.2456.2456
Published: 2004
Journal Articles

Targeting Mitochondrial Factor Smac/DIABLO as Therapy for Multiple Myeloma (MM).

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Teru Hideshima, Ph.D, Klaus Podar, Ph.D, Pierfrancesco Tassone, M.D., Paola E. Neri, M.D., Constantine Mitsiades, Ph.D, Nicholas Mitsiades, M.D., Noopur Raje, M.D., Shaji Kumar, M.D., Robert Schlossman, M.D., Sushil Sharma, M.D., Nikhil Munshi, M.D., Leigh Zawel, Ph.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2004) 104 (11): 764.
https://doi.org/10.1182/blood.V104.11.764.764
Published: 2004